NCT02034318
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
- Locations
-
- University of Miami Miami, Florida, United States
Clinical trial condition
Neurodegenerative Diseases
Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.
9,000 public trials
1,758 recruiting studies
Neurodegenerative Diseases trial results
NCT00998660
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
- Locations
-
- Washington D.C., District of Columbia, United States
- Cincinnati, Ohio, United States
- Nashville, Tennessee, United States
- Houston, Texas, United States
NCT00630851
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Pfizer Investigational Site Fritsla, Sweden
- Pfizer Investigational Site Alunda, Sweden
- Pfizer Investigational Site Aneby, Sweden
- Pfizer Investigational Site Avesta, Sweden
NCT00591344
- Conditions
- Basal Ganglia Diseases, Behavior, Brain Diseases, +9 more
- Locations
-
- Physical Therapy Department at the University of Illinois at Chicago Chicago, Illinois, United States
NCT01481961
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +8 more
- Locations
-
- Psychiatric Department of CHU of Besancon Besançon, France
NCT00983983
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +9 more
- Locations
-
- Barrow Neurological Institute/St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
- University of California at Irvine Irvine, California, United States
- California Pacific Medical Center, University of California at San Francisco San Francisco, California, United States
- Sarasota Memorial Hospital Sarasota, Florida, United States
NCT00406588
- Conditions
- Advanced Stage Parkinson's Disease, Basal Ganglia Diseases, Brain Diseases, +7 more
- Locations
-
- Site 223 Birmingham, Alabama, United States
- Site 220 La Jolla, California, United States
- Site 211 San Francisco, California, United States
- Site 214 Fort Lauderdale, Florida, United States
NCT00977665
- Conditions
- Autonomic Nervous System Diseases, Basal Ganglia Diseases, Brain Diseases, +7 more
- Locations
-
- Teva Investigational Site 1004 Irvine, California, United States
- Teva Investigational Site 1014 La Jolla, California, United States
- Teva Investigational Site 1006 Sunnyvale, California, United States
- Teva Investigational Site 1010 Washington D.C., District of Columbia, United States
Completed
Pharmacokinetic Study in Healthy Males
NCT02312232
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- CRST Turku, Finland
NCT00762411
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Phoenix, Arizona, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Costa Mesa, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Jolla, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Laguna Hills, California, United States